Bank of Montreal
XBIT icon

Bank of Montreal’s XBiotech XBIT Stock Holding History

Bank of Montreal’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30,500
Closed -$120K – 4360
2017
Q4 		$120K Sell
30,500
-2,000
-6% -$8.42K ﹤0.01% 2932
2017
Q3 		$142K Buy
32,500
+7,500
+30% +$35.4K ﹤0.01% 2820
2017
Q2 		$118K Hold
25,000
– – ﹤0.01% 2917
2017
Q1 		$412K Buy
25,000
+16,400
+191% +$215K ﹤0.01% 2173
2016
Q4 		$120K Hold
8,600
– – ﹤0.01% 2746
2016
Q3 		$116K Buy
+8,600
New +$126K ﹤0.01% 2705

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Bank of Montreal's XBIT Position: Q2 2021 in Review

Bank of Montreal sold out of XBiotech (XBIT) in Q2 2021, closing a stake of 439 shares — an estimated $8K sold.

Bank of Montreal first reported a position in XBIT in Q3 2016 and held it in 19 quarters. The position peaked at $412K in Q1 2017. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2021.

  • Bank of Montreal reported no remaining XBiotech position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 439 XBiotech shares in Q2 2021, an estimated $8K.
  • Bank of Montreal first reported a position in XBiotech in Q3 2016 and held it in 19 quarters.
  • Bank of Montreal's XBiotech position peaked at $412K in Q1 2017.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.